The new england journal of medicine: medtronic cryoablation is a superior treatment option for symptomatic paroxysmal atrial fibrillation compared to drug therapy

Dublin, nov. 16, 2020 /prnewswire/ -- medtronic plc (nyse:mdt), the global leader in medical technology, today announced that the primary results of the medtronic-sponsored stop af first clinical trial have been published in the new england journal of medicine (nejm). results from the...
MDT Ratings Summary
MDT Quant Ranking